IBDEI07K ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3231,2)
 ;;=^5019748
 ;;^UTILITY(U,$J,358.3,3232,0)
 ;;=N42.9^^18^216^63
 ;;^UTILITY(U,$J,358.3,3232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3232,1,3,0)
 ;;=3^Prostate Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,3232,1,4,0)
 ;;=4^N42.9
 ;;^UTILITY(U,$J,358.3,3232,2)
 ;;=^5015698
 ;;^UTILITY(U,$J,358.3,3233,0)
 ;;=N40.1^^18^216^65
 ;;^UTILITY(U,$J,358.3,3233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3233,1,3,0)
 ;;=3^Prostate,Enlarged w/ Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,3233,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,3233,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,3234,0)
 ;;=N40.0^^18^216^66
 ;;^UTILITY(U,$J,358.3,3234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3234,1,3,0)
 ;;=3^Prostate,Enlarged w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,3234,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,3234,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,3235,0)
 ;;=N41.9^^18^216^64
 ;;^UTILITY(U,$J,358.3,3235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3235,1,3,0)
 ;;=3^Prostate Inflammatory Disease,Unspec
 ;;^UTILITY(U,$J,358.3,3235,1,4,0)
 ;;=4^N41.9
 ;;^UTILITY(U,$J,358.3,3235,2)
 ;;=^5015694
 ;;^UTILITY(U,$J,358.3,3236,0)
 ;;=C61.^^18^216^62
 ;;^UTILITY(U,$J,358.3,3236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3236,1,3,0)
 ;;=3^Prostate Cancer
 ;;^UTILITY(U,$J,358.3,3236,1,4,0)
 ;;=4^C61.
 ;;^UTILITY(U,$J,358.3,3236,2)
 ;;=^267239
 ;;^UTILITY(U,$J,358.3,3237,0)
 ;;=N40.3^^18^216^67
 ;;^UTILITY(U,$J,358.3,3237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3237,1,3,0)
 ;;=3^Prostate,Nodular w/ Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,3237,1,4,0)
 ;;=4^N40.3
 ;;^UTILITY(U,$J,358.3,3237,2)
 ;;=^5015692
 ;;^UTILITY(U,$J,358.3,3238,0)
 ;;=N40.2^^18^216^68
 ;;^UTILITY(U,$J,358.3,3238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3238,1,3,0)
 ;;=3^Prostate,Nodular w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,3238,1,4,0)
 ;;=4^N40.2
 ;;^UTILITY(U,$J,358.3,3238,2)
 ;;=^5015691
 ;;^UTILITY(U,$J,358.3,3239,0)
 ;;=Z87.430^^18^216^56
 ;;^UTILITY(U,$J,358.3,3239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3239,1,3,0)
 ;;=3^Personal Hx of Prostatic Dysplasia
 ;;^UTILITY(U,$J,358.3,3239,1,4,0)
 ;;=4^Z87.430
 ;;^UTILITY(U,$J,358.3,3239,2)
 ;;=^5063493
 ;;^UTILITY(U,$J,358.3,3240,0)
 ;;=N41.2^^18^216^1
 ;;^UTILITY(U,$J,358.3,3240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3240,1,3,0)
 ;;=3^Abscess of Prostate
 ;;^UTILITY(U,$J,358.3,3240,1,4,0)
 ;;=4^N41.2
 ;;^UTILITY(U,$J,358.3,3240,2)
 ;;=^270416
 ;;^UTILITY(U,$J,358.3,3241,0)
 ;;=N41.0^^18^216^69
 ;;^UTILITY(U,$J,358.3,3241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3241,1,3,0)
 ;;=3^Prostatitis,Acute
 ;;^UTILITY(U,$J,358.3,3241,1,4,0)
 ;;=4^N41.0
 ;;^UTILITY(U,$J,358.3,3241,2)
 ;;=^259106
 ;;^UTILITY(U,$J,358.3,3242,0)
 ;;=N41.1^^18^216^70
 ;;^UTILITY(U,$J,358.3,3242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3242,1,3,0)
 ;;=3^Prostatitis,Chronic
 ;;^UTILITY(U,$J,358.3,3242,1,4,0)
 ;;=4^N41.1
 ;;^UTILITY(U,$J,358.3,3242,2)
 ;;=^186931
 ;;^UTILITY(U,$J,358.3,3243,0)
 ;;=N41.4^^18^216^71
 ;;^UTILITY(U,$J,358.3,3243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3243,1,3,0)
 ;;=3^Prostatitis,Granulomatous
 ;;^UTILITY(U,$J,358.3,3243,1,4,0)
 ;;=4^N41.4
 ;;^UTILITY(U,$J,358.3,3243,2)
 ;;=^52938
 ;;^UTILITY(U,$J,358.3,3244,0)
 ;;=N41.3^^18^216^72
 ;;^UTILITY(U,$J,358.3,3244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3244,1,3,0)
 ;;=3^Prostatocystitis
 ;;^UTILITY(U,$J,358.3,3244,1,4,0)
 ;;=4^N41.3
 ;;^UTILITY(U,$J,358.3,3244,2)
 ;;=^270418
 ;;^UTILITY(U,$J,358.3,3245,0)
 ;;=N70.93^^18^216^73
 ;;^UTILITY(U,$J,358.3,3245,1,0)
 ;;=^358.31IA^4^2
